US reg­u­la­tor ap­proves first drug made with 3D printer

The China Post - - LIFE GUIDE POST -

The U.S. Food and Drug Ad­min­is­tra­tion said Tues­day it has ap­proved the first drug made with a 3D printer — pills for treat­ing epilepsy.

The Ohio-based com­pany Apre­cia Phar­ma­ceu­ti­cals said its sys­tem can pro­duce doses of up to 1,000 mil­ligrams per tablet.

It said the prod­uct is a “por­ous for­mu­la­tion” that dis­solves with just a sip of liq­uid, mak­ing it con­ve­nient for peo­ple who have trou­ble swal­low­ing pills or for get­ting chil­dren to take med­i­ca­tion.

FDA spokes­woman Sandy Walsh con­firmed to AFP that the med­i­ca­tion known as Spri­tam is the first made with a 3D printer that the agency has ap­proved.

Spri­tam, or Leve­tirac­etam, has al­ready been on the mar­ket for years in other for­mats, Walsh said.

Apre­cia, which is not listed, plans to start dis­tribut­ing the med­i­ca­tion in the first quar­ter of next year.

The FDA had al­ready given the green light to other med­i­cal prod­ucts made with such 3D tech­nol­ogy, such as pros­thetic de­vices.

Apre­cia said on its web­site that in com­ing years it plans to de­velop other kinds of med­i­ca­tion with the new tech­nol­ogy.

AP

This prod­uct im­age pro­vided by Apre­cia Phar­ma­ceu­ti­cals shows Spri­tam 750 mil­ligram, fore­ground, and 1000 mil­ligram tablets.

Newspapers in English

Newspapers from Taiwan

© PressReader. All rights reserved.